NCT03561259 2023-02-16
OPTIMUM
Jubilant DraxImage Inc.
Phase 2 Unknown
Clinical Trials
3 trialsNCT01413503 2018-09-18
A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors
University of California, San Francisco
Phase 2 Completed
NCT00028106 2017-07-02
131MIBG to Treat Malignant Pheochromocytoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed